Literature DB >> 18835914

Isovolemic exchange transfusion with increasing concentrations of low oxygen affinity hemoglobin solution limits oxygen delivery due to vasoconstriction.

Pedro Cabrales1, Amy G Tsai, Marcos Intaglietta.   

Abstract

O2-carrying fluids based on hemoglobin (Hb) are in various stages of clinical trials to determine their suitability as O2-carrying plasma expanders. Polymerized Hb solutions are characterized by their vasoactivity, low O2 affinity, oncotic effect, prolonged shelf life, and stability. Physiological responses to facilitated O2 transport after exchange transfusion with polymerized bovine Hb (PBH) were studied in the hamster window chamber model during acute moderate anemia to determine how PBH affects microvascular perfusion and tissue oxygenation. The anemic state [29% hematocrit (Hct)] was induced by hemodilution with a plasma expander (70 kDa dextran). After hemodilution, animals were randomly assigned to different exchange transfusion groups. Study groups were based on the concentration of PBH used, namely: PBH at 13 g Hb/dl [PBH13], PBH diluted to 8 (PBH8) or 4 (PBH4) g Hb/dl in albumin solution at matching colloidal osmotic pressure (COP), and no PBH (only albumin solution) at matching COP (PBH0). Measurement of systemic parameters, microvascular hemodynamics, capillary perfusion, and intravascular and tissue O2 levels was performed at 18% Hct. Restitution of O2-carrying capacity with PBH13 increased arterial pressure and triggered vasoconstriction, low perfusion, and high peripheral resistance. PBH4 and PBH0 exhibited lower arterial pressures compared with PBH13. Exchange transfused animals with PBH8 and PBH4 better maintained perfusion and functional capillary density than PBH13. Blood gas parameters and acid-base balance were recovered proportional to microvascular perfusion. Arterial O2 tensions were improved with PBH4 and PBH8 by preventing O2 precapillary release and increasing O2 reserve. Further studies to establish PBH optimal dosage, efficacy, safety, and its effect on outcome are indicated before Hb-based O2-carrying blood substitutes are implemented in routine practice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18835914      PMCID: PMC2614583          DOI: 10.1152/ajpheart.00751.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  29 in total

1.  Current perceived risks of transfusion in the UK and relevance to the future acceptance of blood substitutes.

Authors:  K C Lowe; K Farrell; E M Ferguson; V James
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  2001-05

2.  EVIDENCE FOR TISSUE OXYGEN DEMAND AS THE MAJOR FACTOR CAUSING AUTOREGULATION.

Authors:  A C GUYTON; O CARRIER; J R WALKER
Journal:  Circ Res       Date:  1964-08       Impact factor: 17.367

3.  Injection of Hemoglobin in Man and its Relation to Blood Destruction, with especial reference to the Anemias.

Authors:  A W Sellards; G R Minot
Journal:  J Med Res       Date:  1916-07

4.  Deferoxamine lowers tissue damage after 80% exchange transfusion with polymerized hemoglobin.

Authors:  Pedro Cabrales; Amy G Tsai; Marcos Intaglietta
Journal:  Antioxid Redox Signal       Date:  2007-03       Impact factor: 8.401

5.  Nitric oxide regulation of microvascular oxygen exchange during hypoxia and hyperoxia.

Authors:  Pedro Cabrales; Amy G Tsai; Marcos Intaglietta
Journal:  J Appl Physiol (1985)       Date:  2005-12-15

Review 6.  Oxygen gradients in the microcirculation.

Authors:  Amy G Tsai; Paul C Johnson; Marcos Intaglietta
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

7.  Microvascular pressure and functional capillary density in extreme hemodilution with low- and high-viscosity dextran and a low-viscosity Hb-based O2 carrier.

Authors:  Pedro Cabrales; Amy G Tsai; Marcos Intaglietta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-02-19       Impact factor: 4.733

8.  Hyperoxic ventilation at the critical hematocrit: effects on myocardial perfusion and function.

Authors:  G I Kemming; F G Meisner; J Meier; J Tillmanns; E Thein; J Eriskat; O P Habler
Journal:  Acta Anaesthesiol Scand       Date:  2004-09       Impact factor: 2.105

9.  Oxygen delivery and consumption in the microcirculation after extreme hemodilution with perfluorocarbons.

Authors:  Pedro Cabrales; Amy G Tsai; John A Frangos; Juan C Briceño; Marcos Intaglietta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-07       Impact factor: 4.733

10.  Pulmonary diffusing capacity: implications of two-phase blood flow in capillaries.

Authors:  W J Federspiel
Journal:  Respir Physiol       Date:  1989-07
View more
  10 in total

1.  Synthesis and characterization of hemoglobin conjugates with antioxidant enzymes via poly(ethylene glycol) cross-linker (Hb-SOD-CAT) for protection from free radical stress.

Authors:  Venkatareddy Nadithe; You Han Bae
Journal:  Int J Biol Macromol       Date:  2010-08-17       Impact factor: 6.953

Review 2.  Perfusion vs. oxygen delivery in transfusion with "fresh" and "old" red blood cells: the experimental evidence.

Authors:  Amy G Tsai; Axel Hofmann; Pedro Cabrales; Marcos Intaglietta
Journal:  Transfus Apher Sci       Date:  2010-06-19       Impact factor: 1.764

3.  Balance between oxygen transport and blood rheology during resuscitation from hemorrhagic shock with polymerized bovine hemoglobin.

Authors:  Alexander T Williams; Alfredo Lucas; Cynthia R Muller; Crystal Bolden-Rush; Andre F Palmer; Pedro Cabrales
Journal:  J Appl Physiol (1985)       Date:  2020-06-18

4.  Biophysical properties and oxygenation potential of high-molecular-weight glutaraldehyde-polymerized human hemoglobins maintained in the tense and relaxed quaternary states.

Authors:  Ning Zhang; Yiping Jia; Guo Chen; Pedro Cabrales; Andre F Palmer
Journal:  Tissue Eng Part A       Date:  2011-01-16       Impact factor: 3.845

Review 5.  Examining and mitigating acellular hemoglobin vasoactivity.

Authors:  Pedro Cabrales
Journal:  Antioxid Redox Signal       Date:  2012-10-11       Impact factor: 8.401

6.  Effects of a hemoglobin-based oxygen carrier (HBOC-201) and derivatives with altered oxygen affinity and viscosity on systemic and microcirculatory variables in a top-load rat model.

Authors:  Bjorn Kyungsuck Song; William H Nugent; Paula F Moon-Massat; Roland N Pittman
Journal:  Microvasc Res       Date:  2014-07-18       Impact factor: 3.514

Review 7.  Blood substitutes: evolution from noncarrying to oxygen- and gas-carrying fluids.

Authors:  Pedro Cabrales; Marcos Intaglietta
Journal:  ASAIO J       Date:  2013 Jul-Aug       Impact factor: 2.872

8.  Vasoactive hemoglobin solution improves survival in hemodilution followed by hemorrhagic shock.

Authors:  Beatriz Y Salazar Vázquez; C Makena Hightower; Judith Martini; Catalina Messmer; Barbara Frienesenecker; Pedro Corbels; Amy G Tsai; Marcos Intaglietta
Journal:  Crit Care Med       Date:  2011-06       Impact factor: 7.598

9.  Vital organ tissue oxygenation after serial normovolemic exchange transfusion with HBOC-201 in anesthetized swine.

Authors:  William W Muir; Govindasamy Ilangovan; Jay L Zweier; Paula F Moon-Massat; Virginia T Rentko
Journal:  Shock       Date:  2011-06       Impact factor: 3.454

10.  Numerical Model for the Determination of Erythrocyte Mechanical Properties and Wall Shear Stress in vivo From Intravital Microscopy.

Authors:  Vivek P Jani; Alfredo Lucas; Vinay P Jani; Carlos Munoz; Alexander T Williams; Daniel Ortiz; Ozlem Yalcin; Pedro Cabrales
Journal:  Front Physiol       Date:  2020-01-23       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.